ALC:NYSE
Alcon AG
63,68 USD
arrow_downward
-0,41%(-0,26) 1 d.
2. 10., 13:14:44 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre ALC…
Otvoriť
64,39 USD
Vysoká
64,42 USD
Nízka
63,50 USD
Trh. kap.
26,25 mld.
Priem. obj.
1,57 mil.
Objem
425,20 tis.
Max. za 52 týž.
87,64 USD
Min. za 52 týž.
61,84 USD
Beta
0,88
Akcie v obehu
483,40 mil.
Počet zamestnancov
25 tis.
Otvoriť
64,39 USD
Vysoká
64,42 USD
Nízka
63,50 USD
Trh. kap.
26,25 mld.
Priem. obj.
1,57 mil.
Objem
425,20 tis.
Max. za 52 týž.
87,64 USD
Min. za 52 týž.
61,84 USD
Beta
0,88
Akcie v obehu
483,40 mil.
Počet zamestnancov
25 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
AD HOC NEWS
·
pred 6 hodinami
Jefferies cuts target for Alcon stock from USD 95.00 to USD 85.00
AD HOC NEWS
·
pred 2 dňami
Alcon stock launches Systane PRO PF in Canada
Simply Wall St
·
pred 2 dňami
Did Dry Eye Drop Launch Just Shift Alcon's (SWX:ALC) Investment Narrative?
AD HOC NEWS
·
pred 3 dňami
Alcon stock gains 1.13 percent to EUR 57.38 after Q2 beat
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Informácie o subjekte Alcon AG
Generálny riaditeľDavid J. Endicott
Zamestnanci25 tis.
Dátum založenia1945
Hlavné sídloŽeneva, Ženeva, Švajčiarsko
Odvetvie-
Webalcon.com